Event Details
Illumina's Next Generation Sequencing has helped to revolutionize genomics research. Genomics, which is the study of a person's genes, changed the world's response to the pandemic and has been integrated into clinical practice at a faster rate than almost any innovation in the history of medicine. But inequities exist. Implementation has been almost entirely restricted to more developed nations, and 70% of the genomes we have today are of Caucasian descent. We need equitable representation in the data, so that therapies and solutions can be attuned to a broader set of genomes, decreasing this bias in our medicine for the future.
Join us at AmCham to learn how Illumina is partnering with like-minded organizations to ensure that genomes can be interpreted in the appropriate context of global diversity and how they will increase the equity of representation in genomic data to drive better health outcomes for all.
* For any enquires please contact the AmCham Programming and Events Team at pe@amcham.com.sg.
* Cancellation Policy: No refunds will be provided for cancellations. Replacements will be accepted.
